WB
Western blot analysis of FGFR2 on different lysates with Rabbit anti-FGFR2 antibody at 1/1,000 dilution.
Lysates/proteins at 15 µg/Lane.
Exposure time: 2 seconds;
FGFR2/KGFR/K-sam recognizes endogenous levels of total FGFR2 protein and a C-terminal truncated form K-sam.
Negative control: SW620.
Blocking: 5% NFDM/TBST, 1 hour at room temperature.
Primary antibody: FGFR2 Recombinant Rabbit Monoclonal Antibody, 1/1,000 in primary antibody dilution buffer, overnight at 4 °C.
Secondary antibody: Goat anti-Rabbit IgG-HRP, 1/50,000 in 5% NFDM/TBST, 1 hour at room temperature.
FC
Application: Flow Cytometry.
Species: Human.
Sample: SW620 (Human colon cancer cell) (Left, Negative) / Saos-2 (Human osteosarcoma cell) (Right).
Blocking: 1% BSA + 10% normal goat serum + human FcR (Miltenyi Biotec), 15 minutes at room temperature.
Antibody dilution buffer: 1x PBS.
Primary antibody: FGFR2 Recombinant Rabbit Monoclonal Antibody (1/1,000, Red) compared with Rabbit IgG Isotype Control (Green), 15 minutes at room temperature.
Secondary antibody: Goat Anti-Rabbit IgG (488), 15 minutes at room temperature.
Negative control: SW620.
IP
FGFR2 was immunoprecipitated in 0.2 mg Saos-2 (Human osteosarcoma cell) cell lysate with FGFR2 Recombinant Rabbit Monoclonal Antibody at 2 µg/10 µl beads. Western blot was performed from the immunoprecipitate using FGFR2 Recombinant Rabbit Monoclonal Antibody at 1/5,000 dilution. Anti-Rabbit IgG for IP,VHH(HRP) at 1/5,000 dilution was used for 1 hour at room temperature.
Lane 1: Saos-2 cell lysate (input).
Lane 2: FGFR2 Recombinant Rabbit Monoclonal Antibody IP in Saos-2 cell lysate.
Lane 3: Rabbit IgG instead of FGFR2 Recombinant Rabbit Monoclonal Antibody in Saos-2 cell lysate.
Exposure time: 3 minutes.
Blocking: 5% NFDM/TBST, 1 hour at room temperature.
Primary dilution: FGFR2 Recombinant Rabbit Monoclonal Antibody, 1/5,000 in primary antibody dilution buffer, 2 hours at room temperature.